$UEEC

United Health Products, Inc.

CIK:0001096938|SEC Filings

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Condensed Statements of Operations (Unaudited)
Revenues	$ 0	$ 0	$ 0	$ 0
Operating Costs and Expenses
Selling, general and administrative expenses	162,998	187,373	416,017	1,560,338
Research and development	3,852	80,983	16,414	204,704
Total Operating Expenses	166,850	268,356	432,431	1,765,042
Loss from Operations	(166,850)	(268,356)	(432,431)	(1,765,042)
Interest expense	(50,456)	(25,100)	(98,565)	(45,812)
Interest expense - related party	(32,936)	(21,731)	(57,492)	(43,462)
Gain (loss) on derivative liabilities	(33,898)	0	(11,494)	0
Total Other Income (Expenses)	(117,290)	(46,831)	(167,551)	(89,274)
Net Loss	$ (284,140)	$ (315,187)	$ (599,982)	$ (1,854,316)
Net Loss per Common Share:
Basic and diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.01)
Weighted average number of shares outstanding	260,040,591	257,139,815	259,369,152	255,684,472

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Flows from Operating Activities:
Net (Loss)	$ (599,982)	$ (1,854,316)
Adjustments to Reconcile Net (Loss) to Net Cash Used In Operating Activities:
Stock for services and compensation	0	1,120,125
Amortization expense	2,025	2,025
Amortization of right-of-use asset	(583)	(110)
Amortization of debt discount	21,222	0
(Gain) loss on derivative liabilities	11,494	0
Security deposit used for rent	2,850	0
Changes in assets and liabilities:
Prepaid and other current assets	(26)	1,914
Accounts payable and accrued expenses	194,423	133,004
Accrued liabilities - related party	54,925	43,462
Accrued compensation	91,300	95,238
Net Cash Used In Operating Activities	(222,352)	(458,658)
Cash Flows from Investing Activities:
Net Cash Used in Investing Activities	0	0
Cash Flows from Financing Activities:
Proceeds from convertible notes payable	0	290,000
Advances from related party	0	20,000
Repayment of advance from related party	0	(20,000)
Proceeds from sale of common stock	100,674	0
Proceeds from notes payable	96,250	0
Repayments of note payable	(15,326)	0
Net Cash Provided by Financing Activities	181,598	290,000
Increase (Decrease) in Cash and Cash Equivalents	(40,754)	(168,658)
Cash and Cash Equivalents - Beginning of period	65,249	168,883
CASH AND CASH EQUIVALENTS - END OF PERIOD	24,495	225
Supplemental cash flow information:
Cash paid for interest	0	0
Cash paid for income taxes	0	0
Non-cash Investing & Financing Activities:
Accrued compensation converted to notes payable - related party	$ 250,000	0
Common stock issued for conversion of convertible notes	50,000
Amortization of deferred offering cost	$ 8,536	0
OID on promissory note - related party	27,778	0
Common stock issued for subscription receivable	$ 0	$ 16,570

Condensed Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current Assets
Cash and cash equivalents	$ 24,495	$ 65,249
Prepaid and other current assets	40,169	40,143
Total current assets	64,664	105,392
Deferred offering costs	161,046	169,582
Operating lease right-of-use asset	0	14,574
Security deposit	0	2,850
Patents, net	22,275	24,300
TOTAL ASSETS	247,985	316,698
Current Liabilities
Accounts payable and accrued expenses	1,355,199	1,160,776
Accrued liabilities - related parties	310,498	255,573
Accrued compensation	541,067	699,767
Operating lease liability - current	0	15,157
Notes payable	80,924	0
Convertible notes payable - related party, net of debt discount	500,000	500,000
Convertible notes payable, net of debt discount	1,247,804	1,279,149
Derivative liabilities	152,742	141,248
Total current liabilities	4,188,234	4,051,670
Notes payable - related party, long-term, net of debt discount	502,567	250,000
TOTAL LIABILITIES	4,690,801	4,301,670
Commitments and Contingencies	0	0
Stockholders' Deficit
Common Stock - $0.001 par value, 300,000,000 shares Authorized, 261,585,588 and 258,690,253 shares issued and outstanding at June 30, 2026 and December 31, 2025	261,585	258,690
Additional Paid-In Capital	77,374,393	77,235,150
Accumulated Deficit	(82,078,794)	(81,478,812)
Total Stockholders' Deficit	(4,442,816)	(3,984,972)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	247,985	316,698
Series A Convertible Preferred Stock [Member]
Stockholders' Deficit
Preferred stock, value	$ 0	$ 0